Globally, the growing diabetic, geriatric, and obese population is expected to drive market growth. Furthermore, rising healthcare awareness among individuals, combined with increased government support, is expected to lead to earlier diagnosis, contributing to the growth of the endocrine testing market.
The rising prevalence of lifestyle diseases is also expected to increase demand for the endocrine test, boosting the market growth. The rising prevalence of diseases such as hypothyroidism and hyperthyroidism is also expected to drive demand for advanced endocrine testing technologies.
To provide highly precise and accurate results, healthcare facilities, laboratories, and diagnostic centers are also employing technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques. Other factors, such as improvements in healthcare infrastructure, are expected to drive the market even further.
Read more @ https://bit.ly/3DaJFPw